Medicare beneficiaries enrolled in Medicare Advantage or Part D prescription drug plans will start receiving Annual Notice of Change documents this September, spelling out every shift in premiums, deductibles, formularies, and provider networks set to take effect in January 2027. Those who toss the notice aside or let it sit unopened will be automatically renewed into the same plan, even if that plan now covers fewer drugs, charges higher copays, or drops their preferred doctors. The window to switch without penalty closes December 7, and the regulatory machinery behind the 2027 plan year is already in motion.
How the September ANOC deadline shapes 2027 costs
Each Medicare Advantage organization and Part D sponsor is required to mail its enrollees an Annual Notice of Change, or ANOC, describing changes effective in January. Beneficiaries should have the document in hand by September. The ANOC is not a marketing brochure; it is a federally standardized disclosure built from templates CMS publishes in its model materials library. CMS has already posted the CY2027 model materials download, which plans must use to format and populate their notices.
The practical risk is straightforward. A beneficiary whose plan raises a drug tier, narrows a network, or increases a specialist copay will see those details spelled out in the ANOC. If that person does nothing, the plan renews on its new terms. The annual open enrollment period, running from October 15 through December 7, exists specifically so people can compare alternatives on Medicare.gov and switch. Skipping that comparison locks in whatever the current plan decided to change.
Because ANOCs arrive months before the new benefits take effect, they function as an early warning system. A higher premium for 2027, the loss of a preferred pharmacy, or a new prior authorization requirement for a key medication will all be listed, often in comparison tables that show 2026 and 2027 side by side. That lead time gives beneficiaries a chance to talk with their doctors, price-test their drugs on the Medicare Plan Finder, and decide whether a different plan better fits their health and budget.
CMS rulemaking and compliance rules behind the 2027 notices
The 2027 plan year is not a routine rollover. CMS published the Contract Year 2027 Medicare Advantage and Part D Final Rule, designated CMS-4208-F3 and CMS-4212-F, which finalizes policy and technical changes affecting benefits, cost-sharing structures, and plan administration. Those federal adjustments flow directly into the benefit packages that plans must disclose in their ANOCs. When a final rule alters how plans can structure formularies or calculate out-of-pocket limits, the resulting changes show up line by line in the notice a beneficiary receives.
CMS has also issued internal guidance through its Health Plan Management System, titled “Reminder of Required Actions,” reinforcing that plans must meet strict mailing and content standards for both the ANOC and the accompanying Evidence of Coverage document. In that HPMS reminder, CMS underscores that failure to send accurate, timely notices can trigger compliance review. Separately, federal regulation under 42 CFR 422.2265 requires Medicare Advantage organizations to post ANOC materials on their websites by October 15 prior to the plan year, creating a digital backstop for anyone who misplaces the mailed copy.
The compliance structure matters to beneficiaries because it means the information in the ANOC is not optional or approximate. Plans are bound by standardized templates and federal deadlines. If a plan fails to send the notice or buries a material change, CMS has enforcement tools. But those protections only help people who actually read what arrives.
Gaps in the evidence and what beneficiaries should do first
While the ANOC and related CMS rules outline what must be disclosed, they do not guarantee that every beneficiary will understand how those changes play out in real life. The documents can be dense, and they rarely include personalized projections of out-of-pocket spending. Evidence on how many people read their ANOC or successfully act on it is limited, and there is no single CMS dataset showing how often beneficiaries are surprised by higher costs in January after ignoring the fall mailings.
Given those gaps, the safest approach is to treat the ANOC as required reading rather than optional fine print. Start by finding the summary section that lists “Changes for 2027” and compare it to how you actually used your coverage this year. If you see higher copays for your regular specialists, new restrictions on a maintenance drug, or a shift in your maximum out-of-pocket limit, flag those items. Then, before December 7, use the Medicare Plan Finder or call 1‑800‑MEDICARE to compare at least one or two alternative plans in your county.
Beneficiaries who feel overwhelmed should not wait until the last week of open enrollment. State Health Insurance Assistance Programs (SHIPs), licensed agents, and some community organizations offer one-on-one counseling, but appointments fill quickly once ANOCs go out. Bringing the notice, a current medication list, and your preferred doctors’ names to any counseling session will make it easier to spot whether a different plan preserves your relationships and keeps drug costs manageable.
The bottom line: CMS can require plans to disclose, standardize the format, and enforce deadlines, but it cannot force anyone to open the envelope. For 2027, the most important step beneficiaries can take is simple but time-sensitive-read the ANOC as soon as it arrives, ask questions about anything that is unclear, and, if needed, make a plan change before the December 7 deadline so that January’s bills match your expectations.
